4584 — Kidswell Bio Cashflow Statement
0.000.00%
- ¥14bn
- ¥12bn
- ¥5bn
- 33
- 26
- 92
- 50
Annual cashflow statement for Kidswell Bio, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1,000 | -534 | -656 | -1,421 | 72.9 |
Depreciation | |||||
Non-Cash Items | 48.1 | -299 | -378 | 85.8 | 13 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -317 | -339 | -388 | 880 | 850 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1,267 | -1,170 | -1,421 | -454 | 937 |
Capital Expenditures | -3.25 | -0.16 | — | — | -6.44 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -19 | 527 | -28.8 | — | 71.5 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -22.3 | 527 | -28.8 | — | 65.1 |
Financing Cash Flow Items | 0.001 | — | — | — | -11.9 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 718 | 369 | 1,356 | 1,618 | -240 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -571 | -274 | -93.8 | 1,164 | 764 |